Platform Revolutionizes Skin Rejuvenation with Dual Ablative/Non-Ablative Effects, Superior Safety for All Skin Types, No Consumables, and Enhanced Topical Delivery Rockwall, Texas–(Newsfile Corp. – February 17, 2026) – Saratoga Technologies, L.L.C. today unveiled Laserase™, an FDA-cleared 1927nm Thulium laser system. This platform combines micro-ablative and non-ablative treatments to address pigmentation disorders, …
Read More »
Matribhumi Samachar English